NASDAQ:CRGX CARGO Therapeutics (CRGX) Stock Price, News & Analysis $18.85 -0.36 (-1.87%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$18.44▼$19.4450-Day Range$13.84▼$19.2152-Week Range$13.14▼$33.92Volume196,293 shsAverage Volume247,587 shsMarket Capitalization$864.50 millionP/E RatioN/ADividend YieldN/APrice Target$30.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get CARGO Therapeutics alerts: Email Address CARGO Therapeutics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside60.9% Upside$30.33 Price TargetShort InterestBearish12.92% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.69Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($4.37) to ($4.86) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.60 out of 5 starsMedical Sector683rd out of 910 stocksBiological Products, Except Diagnostic Industry111th out of 155 stocks 3.5 Analyst's Opinion Consensus RatingCARGO Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCARGO Therapeutics has only been the subject of 3 research reports in the past 90 days.Read more about CARGO Therapeutics' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted12.92% of the float of CARGO Therapeutics has been sold short.Short Interest Ratio / Days to CoverCARGO Therapeutics has a short interest ratio ("days to cover") of 16.7, which indicates bearish sentiment.Change versus previous monthShort interest in CARGO Therapeutics has recently decreased by 5.99%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCARGO Therapeutics does not currently pay a dividend.Dividend GrowthCARGO Therapeutics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRGX. Previous Next 2.6 News and Social Media Coverage News SentimentCARGO Therapeutics has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for CARGO Therapeutics this week, compared to 2 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CARGO Therapeutics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.38% of the stock of CARGO Therapeutics is held by insiders.Percentage Held by Institutions93.16% of the stock of CARGO Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CARGO Therapeutics' insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for CARGO Therapeutics are expected to decrease in the coming year, from ($4.37) to ($4.86) per share.Price to Book Value per Share RatioCARGO Therapeutics has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about CARGO Therapeutics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About CARGO Therapeutics Stock (NASDAQ:CRGX)CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.Read More CRGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRGX Stock News HeadlinesAugust 30, 2024 | americanbankingnews.comAnalysts Set CARGO Therapeutics, Inc. (NASDAQ:CRGX) PT at $30.33August 16, 2024 | investorplace.comCRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024September 7, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.August 16, 2024 | fool.comWhy Cargo Therapeutics Stock Rocketed Nearly 20% Higher This WeekAugust 15, 2024 | uk.investing.comCargo Therapeutics stock target cut amid accelerating trial enrollmentAugust 13, 2024 | markets.businessinsider.comCARGO Therapeutics: Strong Buy on Robust Financials and Promising Clinical TrialsAugust 12, 2024 | globenewswire.comCARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateJuly 29, 2024 | finance.yahoo.comWith 54% ownership of the shares, CARGO Therapeutics, Inc. (NASDAQ:CRGX) is heavily dominated by institutional ownersSeptember 7, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.July 24, 2024 | msn.comHC Wainwright & Co. Initiates Coverage of CARGO Therapeutics (CRGX) with Buy RecommendationJuly 20, 2024 | finance.yahoo.comAbivax SA (2X1.SG)June 4, 2024 | globenewswire.comCARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent DirectorMay 30, 2024 | investorplace.comUndiscovered Stocks on the Verge of a Breakout: 3 Names to Know NowMay 28, 2024 | marketwatch.comCargo Therapeutics Shares Drop 17% After Private Placement NewsMay 28, 2024 | globenewswire.comCARGO Therapeutics to Participate in Upcoming Investor ConferencesMay 28, 2024 | globenewswire.comCARGO Therapeutics Announces $110.0 Million Private Placement Equity FinancingMay 14, 2024 | markets.businessinsider.comCARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | globenewswire.comCARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateSee More Headlines Receive CRGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CARGO Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2024Today9/07/2024Next Earnings (Estimated)12/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CRGX Previous SymbolNASDAQ:CRGX CUSIPN/A CIK1966494 Webcargo-tx.com Phone650-379-6143FaxN/AEmployees116Year FoundedN/APrice Target and Rating Average Stock Price Target$30.33 High Stock Price Target$34.00 Low Stock Price Target$23.00 Potential Upside/Downside+60.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-98,150,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-50.68% Return on Assets-38.69% Debt Debt-to-Equity RatioN/A Current Ratio16.96 Quick Ratio16.96 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$9.50 per share Price / Book1.98Miscellaneous Outstanding Shares45,862,000Free Float45,229,000Market Cap$864.50 million OptionableN/A BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMs. Gina Chapman (Age 56)President, CEO & Director Comp: $755.35kDr. Crystal L. Mackall M.D. (Age 63)Co-Founder Comp: $160kDr. Shishir Gadam Ph.D. (Age 57)Chief Technical Officer Comp: $674.03kDr. Robbie Majzner M.D.Founder & Chair of Scientific Advisory BoardMs. Nancy Goodman J.D.FounderDr. Louai LabaniehFounderMr. Anup Radhakrishnan (Age 44)CFO, Secretary & Chief Business Officer Dr. Corinne D. Epperly M.D. (Age 46)M.P.H., Chief Operating Officer Mr. Faisal Shawwa M.B.A.Senior Vice President of Finance & AccountingDr. Michael Ports Ph.D. (Age 43)Chief Scientific Officer More ExecutivesKey CompetitorsTG TherapeuticsNASDAQ:TGTXBiohavenNYSE:BHVNHUTCHMEDNASDAQ:HCMXenon PharmaceuticalsNASDAQ:XENESpringWorks TherapeuticsNASDAQ:SWTXView All CompetitorsInsiders & InstitutionsNovo Holdings A SBought 294,000 shares on 8/20/2024Ownership: 3.367%Perceptive Advisors LLCBought 235,000 shares on 8/16/2024Ownership: 8.031%The Manufacturers Life Insurance Company Bought 26,808 shares on 8/15/2024Ownership: 0.347%CVI Holdings LLCBought 70,000 shares on 8/15/2024Ownership: 0.153%Yu FanBought 912,000 shares on 8/14/2024Ownership: 1.989%View All Insider TransactionsView All Institutional Transactions CRGX Stock Analysis - Frequently Asked Questions How have CRGX shares performed this year? CARGO Therapeutics' stock was trading at $23.15 at the start of the year. Since then, CRGX shares have decreased by 18.6% and is now trading at $18.85. View the best growth stocks for 2024 here. How were CARGO Therapeutics' earnings last quarter? CARGO Therapeutics, Inc. (NASDAQ:CRGX) issued its earnings results on Monday, August, 12th. The company reported ($1.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.06) by $0.04. When did CARGO Therapeutics IPO? CARGO Therapeutics (CRGX) raised $281 million in an initial public offering (IPO) on Friday, November 10th 2023. The company issued 18,750,000 shares at a price of $15.00 per share. Who are CARGO Therapeutics' major shareholders? CARGO Therapeutics' top institutional shareholders include Perceptive Advisors LLC (8.03%), Novo Holdings A S (3.37%), Yu Fan (1.99%) and Cowen AND Company LLC (1.21%). Insiders that own company stock include Samsara Biocapital Gp, Llc and Perceptive Advisors Llc. View institutional ownership trends. How do I buy shares of CARGO Therapeutics? Shares of CRGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CRGX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRGX Stock Alerts